In March 2020, at the outset of the current pandemic, ESOPRS issued detailed advice on the appropriate procedures that practicing oculoplastic surgeons should consider to limit the transmission of COVID-19, with this information updated in April 2020. This paper highlights the threat to training opportunities for future generations of oculoplastic surgeons, adjustments in healthcare delivery, modifications of scientific activity, and the possible role of telemedicine in oculoplastics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/01676830.2020.1808022 | DOI Listing |
Ophthalmic Plast Reconstr Surg
December 2024
Ophthalmology Department, Tzafon Medical Center, Azrieli Faculty of Medicine, Bar Ilan University, Israel.
Purpose: This study aimed to compare the effectiveness of 3 artificial intelligence language models-GPT-3.5, GPT-4o, and Gemini, in delivering patient-centered information about thyroid eye disease (TED). We evaluated their performance based on the accuracy and comprehensiveness of their responses to common patient inquiries regarding TED.
View Article and Find Full Text PDFOrbit
December 2024
Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, USA.
Purpose: Online health information seekers may access information produced by artificial intelligence language models such as ChatGPT (OpenAI). The medical field may pose a significant challenge for incorporating these applications given the training and experience needed to master clinical reasoning. The objective was to evaluate the performance of ChatGPT responses compared to human oculofacial plastic surgeon (OPS) responses to FAQs about an upper eyelid blepharoplasty procedure.
View Article and Find Full Text PDFInt Ophthalmol
December 2024
Department of Ophthalmology, Division of Oculoplastic and Lacrimal Surgery Unit, Erciyes University Medical Faculty, Kayseri, Türkiye.
Purpose: We evaluated the surgical outcomes and management of complications associated with the minimally invasive conjunctivodacryocystorhinostomy using the StopLoss Jones (SLJT) tube of proximal lacrimal canal obstruction.
Methods: The study retrospectively included 22 eyes of 15 patients who underwent SLJT for proximal canalicular obstruction. Age, gender, follow-up duration, etiology of canalicular obstruction, previous surgery, tube size, complications, and the need for additional surgical intervention were assessed.
Eur J Ophthalmol
December 2024
Department of Oculoplastic Surgery, Texas Oculoplastic Consultants: TOC Eye and Face, Austin, Texas, USA.
Methods: The authors performed a computerized search using PubMed, Embase, and Google Scholar. The search terms used were "chemotherapy AND surgery", "immunotherapy AND surgery", "radiotherapy AND surgery", "nutrition AND surgery", "(oculoplastic OR orbit OR eyelid OR lacrimal OR puncta) AND (chemotherapy OR immunotherapy OR radiotherapy)", "(facial OR facial plastic OR oculoplastic) AND (chemotherapy OR immunotherapy OR radiotherapy)", "(cancer OR malignancy) AND surgery", "(cancer OR malignancy) AND (surgery OR surgical) complications", "wound healing AND (cancer OR malignancy)", "infection AND (cancer OR malignancy)", "(bleeding OR blood loss) AND (cancer OR malignancy) AND surgery", "(chemotherapy OR immunotherapy OR radiotherapy) AND wound healing", "(chemotherapy OR immunotherapy OR radiotherapy) AND (bleeding OR blood loss)", "(chemotherapy OR immunotherapy OR radiotherapy) AND infection".
Results: A total of 89 articles, published from 1993 to 2023 in the English language or with English translations were included.
Aesthet Surg J
November 2024
Dermatologist in private practice, Hunt Valley, MD, USA.
Background: Botulinum neurotoxins used in aesthetic medicine require reconstitution before administration, which may be inconvenient and present errors among injectors.
Objectives: Evaluate the efficacy and safety of ready-to-use nivobotulinumtoxinA liquid formulation for the treatment of glabellar lines (GL) with/without treatment of lateral canthal lines (LCL).
Methods: Two multicenter, phase 3, double-blind, randomized trials enrolled participants with moderate-to-severe GL (Study 001) or moderate-to-severe GL+LCL (Study 005).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!